RET and cancer: Although, both oncoproteins, BRAF V600E and RET/PTC1, share common property of signaling via activation of MEK-ERK kinase pathway, they have unique phenotypic features, signifying that the different tumor biology may characterize cancers arising from different oncogenes [42], [43], [44].